Zdrowie i gospodarka · 11.08.2004
Change of Names and Addresses; Technical Amendment
The Food and Drug Administration (FDA) is amending its regulations to reflect name and address changes for the Office of Compliance, Center for Drug Evaluation and Research (CDER). This action is editorial in nature and is intended to provide accuracy and clarity to the agency's regulations.